老年高血压患者动态血压特点及其与脑卒中关系

The Dynamic Blood Pressure Characteristics of Elderly Hypertensive Patients and Its Relationship with Cerebral Apoplexy

目的:探讨老年高血压患者动态血压特点与脑卒中的关系。方法:选择2013年2月-2014年2月本院收治的267例高血压患者作为研究对象,根据患者的年龄将其分为老年组149例(A组)和非老年组118例(B组)。在此基础上再次进行分组,根据患者是否合并脑卒中将上述两组分为脑卒中组A1和B1以及非脑卒中组A2和B2。对患者进行动态血压监测,观察两组患者的血压特点并分析其与脑卒中的关系。结果:A组血压的昼夜节律性低于B组,差异有统计学意义(P<0.05)。A组脉压与B组比较差异有统计学意义(P<0.05),并且A1组夜间收缩压明显高于其余三组(P<0.05)。结论:血压昼夜节律降低、动态血压脉压增大及夜间收缩压增高是老年高血压患者并发脑卒中的重要原因,掌握老年高血压的变化特点并分析其与脑卒中之间的关系可以有效预防由该病引发的心血管疾病,并通过个体性的治疗方案保障临床治疗效果。

Objective： To study the dynamic blood pressure characteristics of elderly hypertensive patients and its relationship with cerebral apoplexy.Method：267 hypertension patients were selected as the research object in our hospital from February 2013 to February 2014,they were divided into the elderly group（the group A,149 patients）and the non-elderly group（the group B,118 patients）according to patients’ age. On the basis of this group again,according to whether patients with combined stroke will be divided into the stroke group A1 and B1 and the non-stroke group A2 and B2. Ambulatory blood pressure of 267 cases were monitored,the blood pressure characteristics two groups was observed and its relationship with cerebral apoplexy was analyzed.Result：In the group A whether merger or stroke,its blood pressure circadian rhythm was lower than that in the group B（P〈0.05）;the pulse pressure pulse pressure had significant difference between the group A and the group B（P〈0.05）. Nighttime systolic blood pressure of the A1 group was obviously higher than that of the rest of the three groups（P〈0.05）.Conclusion：Low blood pressure circadian rhythm,pressing of arteries and veins increases blood pressure and systolic blood pressure at night increased dynamic is one of the reasons for the elderly patients with hypertension complicated by stroke,to analyze the change characteristics of senile hypertension and its and the relationship between cerebral apoplexy can effectively prevent the disease caused by cardiovascular disease, and through the individual treatment plan to ensure the clinical therapeutic effect.